Frontlight ResearchEarly access
Trial site
Yiyang Central Hospital
- 3running trials
- 3closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease1 trial
- Liver cirrhosis1 trial
- Lung cancer1 trial
- Stroke1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 22 trials
- Phase 32 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed3 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Beijing Protgen Biotechnology Development Co., Ltd.1 trial
- Capital Medical University1 trial
- RemeGen Co., Ltd.1 trial
- Shenzhen HighTide Biopharmaceutical Ltd.1 trial
- SPH Qingdao Growful Pharmacetical Co.,Ltd1 trial
- and 1 more
Running trials
Recruiting
Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Coronary artery disease1 recruiting
- Lung cancer1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026